EditorialEditorials

Respiratory Support in Patients With Amyotrophic Lateral Sclerosis

Loutfi S Aboussouan and Eduardo Mireles-Cabodevila
Respiratory Care September 2013, 58 (9) 1555-1558; DOI: https://doi.org/10.4187/respcare.02710

References

  1. 1.↵
    1. Vandenberghe N,
    2. Vallet AE,
    3. Petitjean T,
    4. Le Cam P,
    5. Peysson S,
    6. Guérin C,
    7. et al
    . Absence of airway secretion accumulation predicts tolerance of noninvasive ventilation in subjects with amyotrophic lateral sclerosis. Respir Care 2013;58(9):1424-1432.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Vitacca M,
    2. Vianello A
    , on behalf of the Scientific Group on Respiratory Intensive Care of the Italian Association of Hospital Pulmonologists. Respiratory outcomes of patients with amyotrophic lateral sclerosis: an Italian nationwide survey. Respir Care 2013;58(9):1433-1441.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Miller RG,
    2. Mitchell JD,
    3. Lyon M,
    4. Moore DH
    . Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2007;(1):CD001447.
  4. 4.↵
    1. Bourke SC,
    2. Tomlinson M,
    3. Williams TL,
    4. Bullock RE,
    5. Shaw PJ,
    6. Gibson GJ
    . Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006;5(2):140-147.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Aboussouan LS,
    2. Khan SU,
    3. Banerjee M,
    4. Arroliga AC,
    5. Mitsumoto H
    . Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve 2001;24(3):403-409.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Kleopa KA,
    2. Sherman M,
    3. Neal B,
    4. Romano GJ,
    5. Heiman-Patterson T
    . BiPAP improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 1999;164(1):82-88.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation: a consensus conference report. Chest 1999;116(2):521-534.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Miller RG,
    2. Jackson CE,
    3. Kasarskis EJ,
    4. England JD,
    5. Forshew D,
    6. Johnston W,
    7. et al
    . Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73(15):1218-1226.
    OpenUrlCrossRef
  9. 9.↵
    1. Bourke SC,
    2. Bullock RE,
    3. Williams TL,
    4. Shaw PJ,
    5. Gibson GJ
    . Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 2003;61(2):171-177.
    OpenUrlCrossRef
  10. 10.↵
    1. Jackson CE,
    2. Lovitt S,
    3. Gowda N,
    4. Anderson F,
    5. Miller RG
    . Factors correlated with NPPV use in ALS. Amyotroph Lateral Scler 2006;7(2):80-85.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Yuen EC,
    2. Olney RK
    . Longitudinal study of fiber density and motor unit number estimate in patients with amyotrophic lateral sclerosis. Neurology 1997;49(2):573-578.
    OpenUrl
  12. 12.↵
    1. Schmidt EP,
    2. Drachman DB,
    3. Wiener CM,
    4. Clawson L,
    5. Kimball R,
    6. Lechtzin N
    . Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve 2006;33(1):127-132.
    OpenUrlPubMed
  13. 13.↵
    1. Gruis KL,
    2. Brown DL,
    3. Schoennemann A,
    4. Zebarah VA,
    5. Feldman EL
    . Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve 2005;32(6):808-811.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Jackson CE,
    2. Rosenfeld J,
    3. Moore DH,
    4. Bryan WW,
    5. Barohn RJ,
    6. Wrench M,
    7. et al
    . A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci 2001;191(1-2):75-78.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Pinto A,
    2. de Carvalho M,
    3. Evangelista T,
    4. Lopes A,
    5. Sales-Luis L
    . Nocturnal pulse oximetry: a new approach to establish the appropriate time for non-invasive ventilation in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4(1):31-35.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Lechtzin N,
    2. Scott Y,
    3. Busse AM,
    4. Clawson LL,
    5. Kimball R,
    6. Wiener CM
    . Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler 2007;8(3):185-188.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Aboussouan LS,
    2. Khan SU,
    3. Meeker DP,
    4. Stelmach K,
    5. Mitsumoto H
    . Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997;127(6):450-453.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Miller RG,
    2. Anderson F,
    3. Brooks BR,
    4. Mitsumoto H,
    5. Bradley WG,
    6. Ringel SP
    . Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Ann Neurol 2009;65(Suppl 1):S24-S28.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Olney RK,
    2. Murphy J,
    3. Forshew D,
    4. Garwood E,
    5. Miller BL,
    6. Langmore S,
    7. et al
    . The effects of executive and behavioral dysfunction on the course of ALS. Neurology 2005;65(11):1774-1777.
    OpenUrlCrossRef
  20. 20.↵
    1. Cedarbaum JM,
    2. Stambler N,
    3. Malta E,
    4. Fuller C,
    5. Hilt D,
    6. Thurmond B,
    7. Nakanishi A
    . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169(1-2):13-21.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Norris FH Jr.,
    2. Calanchini PR,
    3. Fallat RJ,
    4. Panchari S,
    5. Jewett B
    . The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974;24(8):721-728.
    OpenUrl
  22. 22.↵
    1. Fattori B,
    2. Grosso M,
    3. Bongioanni P,
    4. Nacci A,
    5. Cristofani R,
    6. AlSharif A,
    7. et al
    . Assessment of swallowing by oropharyngoesophageal scintigraphy in patients with amyotrophic lateral sclerosis. Dysphagia 2006;21(4):280-286.
    OpenUrlPubMed
  23. 23.↵
    1. Suarez AA,
    2. Pessolano FA,
    3. Monteiro SG,
    4. Ferreyra G,
    5. Capria ME,
    6. Mesa L,
    7. et al
    . Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease. Am J Phys Med Rehabil 2002;81(7):506-511.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Kuhnlein P,
    2. Gdynia HJ,
    3. Sperfeld AD,
    4. Lindner-Pfleghar B,
    5. Ludolph AC,
    6. Prosiegel M,
    7. Riecker A
    . Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol 2008;4(7):366-374.
    OpenUrlPubMed
  25. 25.↵
    1. Yunusova Y,
    2. Green JR,
    3. Wang J,
    4. Pattee G,
    5. Zinman L
    . A protocol for comprehensive assessment of bulbar dysfunction in amyotrophic lateral sclerosis (ALS). J Vis Exp 2011;(48). DOI: 10.3791/2422. http://www.jove.com/video/2422/a-protocol-for-comprehensive-assessment-bulbar-dysfunction. Accessed July 3, 2013.
  26. 26.↵
    1. Sancho J,
    2. Servera E,
    3. Diaz J,
    4. Marin J
    . Predictors of ineffective cough during a chest infection in patients with stable amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2007;175(12):1266-1271.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Ravits J,
    2. Paul P,
    3. Jorg C
    . Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007;68(19):1571-1575.
    OpenUrlCrossRef
  28. 28.↵
    1. Ravits J,
    2. Laurie P,
    3. Fan Y,
    4. Moore DH
    . Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 2007;68(19):1576-1582.
    OpenUrlCrossRef
  29. 29.↵
    1. McCool FD,
    2. Tzelepis GE
    . Dysfunction of the diaphragm. N Engl J Med 2012;366(10):932-942.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Gonzalez-Bermejo J,
    2. Morelot-Panzini C,
    3. Salachas F,
    4. Redolfi S,
    5. Straus C,
    6. Becquemin MH,
    7. et al
    . Diaphragm pacing improves sleep in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2012;13(1):44-54.
    OpenUrlPubMed
  31. 31.↵
    1. Onders RP,
    2. Elmo M,
    3. Khansarinia S,
    4. Bowman B,
    5. Yee J,
    6. Road J,
    7. et al
    . Complete worldwide operative experience in laparoscopic diaphragm pacing: results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients. Surg Endosc 2009;23(7):1433-1440.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Nishino T
    . Problems associated with diaphragm pacing. Respiration 2002;69(1):12-13.
    OpenUrlPubMed
  33. 33.↵
    1. Senent C,
    2. Golmard JL,
    3. Salachas F,
    4. Chiner E,
    5. Morelot-Panzini C,
    6. Meninger V,
    7. et al
    . A comparison of assisted cough techniques in stable patients with severe respiratory insufficiency due to amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011;12(1):26-32.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Chatwin M,
    2. Simonds AK
    . The addition of mechanical insufflation/exsufflation shortens airway-clearance sessions in neuromuscular patients with chest infection. Respir Care 2009;54(11):1473-1479.
    OpenUrlAbstract/FREE Full Text
  35. 35.
    1. Vitacca M,
    2. Paneroni M,
    3. Trainini D,
    4. Bianchi L,
    5. Assoni G,
    6. Saleri M,
    7. et al
    . At home and on demand mechanical cough assistance program for patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil 2010;89(5):401-406.
    OpenUrlCrossRefPubMed
  36. 36.
    1. Moran FC,
    2. Spittle A,
    3. Delany C,
    4. Robertson CF,
    5. Massie J
    . Effect of home mechanical in-exsufflation on hospitalisation and life-style in neuromuscular disease: a pilot study. J Paediatr Child Health 2013;49(3):233-237.
    OpenUrlPubMed
  37. 37.↵
    1. Miske LJ,
    2. Hickey EM,
    3. Kolb SM,
    4. Weiner DJ,
    5. Panitch HB
    . Use of the mechanical in-exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest 2004;125(4):1406-1412.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Sancho J,
    2. Servera E,
    3. Banuls P,
    4. Marin J
    . Prolonging survival in amyotrophic lateral sclerosis: efficacy of noninvasive ventilation and uncuffed tracheostomy tubes. Am J Phys Med Rehabil 2010;89(5):407-411.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Vianello A,
    2. Arcaro G,
    3. Palmieri A,
    4. Ermani M,
    5. Braccioni F,
    6. Gallan F,
    7. et al
    . Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. J Crit Care 2011;26(3):329.e7-e14.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Bach JR,
    2. Goncalves MR,
    3. Hon A,
    4. Ishikawa Y,
    5. De Vito EL,
    6. Prado F,
    7. Dominguez ME
    . Changing trends in the management of end-stage neuromuscular respiratory muscle failure: recommendations of an international consensus. Am J Phys Med Rehabil 2013;92(3):267-277.
    OpenUrlPubMed
  41. 41.↵
    1. Qureshi M,
    2. Schoenfeld DA,
    3. Paliwal Y,
    4. Shui A,
    5. Cudkowicz ME
    . The natural history of ALS is changing: improved survival. Amyotroph Lateral Scler 2009;10(5-6):324-331.
    OpenUrlCrossRefPubMed
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...